Truepoint Inc. increased its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,614 shares of the pharmacy operator’s stock after buying an additional 39 shares during the quarter. Truepoint Inc.’s holdings in Walgreens Boots Alliance were worth $698,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Reilly Financial Advisors LLC grew its stake in shares of Walgreens Boots Alliance by 7.9% during the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares during the period. Orrstown Financial Services Inc. grew its stake in shares of Walgreens Boots Alliance by 14.1% during the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 213 shares during the period. MCF Advisors LLC grew its stake in shares of Walgreens Boots Alliance by 68.2% during the 1st quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock worth $160,000 after purchasing an additional 780 shares during the period. Founders Capital Management acquired a new stake in shares of Walgreens Boots Alliance during the 1st quarter worth approximately $161,000. Finally, Modera Wealth Management LLC grew its stake in shares of Walgreens Boots Alliance by 0.4% during the 1st quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock worth $204,000 after purchasing an additional 9 shares during the period. Institutional investors own 60.14% of the company’s stock.

Walgreens Boots Alliance, Inc. (WBA) opened at 67.40 on Wednesday. Walgreens Boots Alliance, Inc. has a one year low of $66.92 and a one year high of $89.69. The firm has a 50-day moving average price of $78.27 and a 200-day moving average price of $80.61. The stock has a market cap of $72.12 billion, a price-to-earnings ratio of 17.02 and a beta of 1.25.

Walgreens Boots Alliance declared that its board has authorized a stock buyback program on Thursday, June 29th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to purchase up to 5.9% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s management believes its stock is undervalued.

A number of brokerages have recently commented on WBA. Zacks Investment Research cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday. SunTrust Banks, Inc. set a $72.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a research note on Sunday. Needham & Company LLC reaffirmed a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, October 12th. Morgan Stanley cut shares of Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $95.00 to $85.00 in a research note on Friday, October 6th. Finally, BidaskClub cut shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Tuesday, October 3rd. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Buy” and a consensus target price of $90.18.

WARNING: This report was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another website, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/10/18/truepoint-inc-raises-position-in-walgreens-boots-alliance-inc-wba.html.

In related news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the transaction, the director now directly owns 19,151 shares in the company, valued at $1,528,058.29. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.